Henrik Daub

Company: NEOsphere Biotechnologies

Job title: Chief Scientific officer

Seminars:

Deep Proteomic Screening for Systematic Discovery of Novel Degrader Targets 11:45 am

High-throughput proteome-wide degrader characterization with unparalleled sensitivity, data completeness, and turnaround times  Identification of novel degrader targets, monitoring of proteome-wide selectivity, and detection of molecules acting through new E3 ligases and emerging TPD mechanisms. Demonstration of degrader-induced modification by ubiquitinomics to a depth of up to 50.000 sites and detection of degrader-induced E3 ligase binding…Read more

day: Day 1 Track A AM